← Back to GENB

Generate Biomedicines, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026
$6.3$7.2$10$8.8
−$67−$61−$52−$42
−$0.52−$1.07−$1.94−$1.62
128653333

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.